BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 10, 2006
View Archived Issues
Catumaxomab opsonization of lymphocytes feasible in refractory cancer
Read More
Celecoxib investigated in acute renal colic
Read More
Preclinical update on IPI-504 in MM, breast and pancreatic cancers
Read More
SuperGen completes acquisition of Montigen Pharmaceuticals
Read More
Pharmos prioritizes Vela compounds
Read More
Phase II study of ceftaroline in cSSSI completes enrollment
Read More
Vertex begins phase II program for VX-680
Read More
Intercell and Kirin Brewery to develop antibodies to treat pneumococcal infections
Read More
Adherex and NCI execute clinical trial agreement for ADH-1
Read More
REP-9 has potent antiviral activity against avian H5N1 influenza virus
Read More
ReNeuron to raise fund through international placing
Read More
Cytogen submits IND for CYT-500
Read More
Ganymed antibodies show efficacy in mouse tumor models
Read More
Kissei licenses rights to novel antidiabetic agent KGA-2727 to GlaxoSmithKline
Read More
EpiCept presents new SARS-CoV protease inhibitor
Read More
Roche reports new agents for thrombotic disorders
Read More
New agents for treating endocrine-related disorders disclosed in recent patents
Read More
Recent patents report new therapeutic agents for metabolic disorders
Read More
Orally active steroid from SRI proven to inhibit both angiogenesis and tumor growth
Read More
SMAC-mimetics induce apoptosis in combination with TRAIL in bladder cancer cells
Read More
Daytrana approved for use in ADHD
Read More
Potential development candidate for prostate cancer bone metastases presented by Lilly
Read More
Revlimid multiple myeloma MAA accepted for review in Europe
Read More
Pramipexole approved in Europe for restless legs syndrome
Read More
Novel chemopotentiating p38 MAPK inhibitor developed at Lilly
Read More
New PARG inhibitors for the treatment of Parkinson's disease identified
Read More
Interim phase I results reported for AAV-GAD gene therapy for Parkinson's disease
Read More
Novel series of apoptosis inducers presented by Maxim and Shire
Read More